S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NYSE:CLVT

Clarivate (CLVT) Stock Price, News & Analysis

$7.43
-0.03 (-0.40%)
(As of 03/28/2024 ET)
Today's Range
$7.43
$7.59
50-Day Range
$7.01
$9.44
52-Week Range
$6.07
$10.03
Volume
4.37 million shs
Average Volume
4.04 million shs
Market Capitalization
$4.96 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Clarivate MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
7.7% Upside
$8.00 Price Target
Short Interest
Bearish
9.18% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.74mentions of Clarivate in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
8.06%
From $0.62 to $0.67 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.73 out of 5 stars

Computer And Technology Sector

542nd out of 589 stocks

Data Processing & Preparation Industry

50th out of 55 stocks

CLVT stock logo

About Clarivate Stock (NYSE:CLVT)

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.

CLVT Stock Price History

CLVT Stock News Headlines

Altcoin FRENZY Alert…
Bitcoin recently crossed the highest price in its 15-year history… Less than 2 years after one of the most vicious crypto market meltdowns we've ever seen! Bitcoin's BOOM also sent shockwaves through the altcoin market, with select coins seeing HUGE moves in a matter of days… Like Fetch.ai, that gained over 350% in just the last 30 days…
Comparing Sterling Check (NASDAQ:STER) & Clarivate (NYSE:CLVT)
CLVT Oct 2024 5.000 put
CLVT Jul 2024 7.500 put
Major Elon Musk Crypto Leak Revealed
Reports of a leaked meeting between Elon Musk and staff at X.com could send shockwaves through the crypto market. Musk revealed a "mind-blowing" plan to take over the global payment system. In his own words, the world's richest man said "you won't need a bank account." Prominent voices in crypto believe what comes next will mirror a crypto mass adoption similar to the one that triggered bitcoin's last bull run.
Clarivate Reveals Top 100 Global Innovators 2024
Exor N.V.: Clarivate and Exor sign agreement
Clarivate and Exor sign agreement
The Analyst Landscape: 5 Takes On Clarivate
See More Headlines
Receive CLVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Clarivate and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/27/2024
Today
3/29/2024
Next Earnings (Estimated)
5/14/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Data processing & preparation
Sub-Industry
N/A
Fax
N/A
Employees
12,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$10.00
Low Stock Price Target
$6.00
Potential Upside/Downside
+7.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
9 Analysts

Profitability

Net Income
$-911,200,000.00
Pretax Margin
-38.52%

Debt

Sales & Book Value

Annual Sales
$2.63 billion
Cash Flow
$1.84 per share
Book Value
$6.93 per share

Miscellaneous

Free Float
514,573,000
Market Cap
$4.96 billion
Optionable
Optionable
Beta
1.25
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Mr. Jonathan Gear (Age 53)
    CEO & Director
    Comp: $1.3M
  • Mr. Jonathan M. Collins (Age 44)
    Executive VP & CFO
    Comp: $1.96M
  • Mr. Gordon Samson (Age 58)
    President of Intellectual Property
    Comp: $1.02M
  • Mr. Michael Easton (Age 51)
    Senior VP of Finance & Chief Accounting Officer
  • Mr. William E. Graff
    Chief Information Officer
  • Mr. Mark J. Donohue
    Head of Investor Relations
  • Ms. Melanie D. Margolin J.D. (Age 52)
    Chief Legal Officer
  • Ms. Tabita Andersson
    Senior Vice President of Communications & Brand
  • Ms. Julia M. Wilson (Age 61)
    Chief People Officer
  • Mr. Richard C. Finch
    Global Head of Life Sciences Consulting Services

CLVT Stock Analysis - Frequently Asked Questions

Should I buy or sell Clarivate stock right now?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Clarivate in the last year. There are currently 3 sell ratings, 3 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CLVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CLVT, but not buy additional shares or sell existing shares.
View CLVT analyst ratings
or view top-rated stocks.

What is Clarivate's stock price target for 2024?

9 brokers have issued 12-month price objectives for Clarivate's stock. Their CLVT share price targets range from $6.00 to $10.00. On average, they anticipate the company's stock price to reach $8.00 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for CLVT
or view top-rated stocks among Wall Street analysts.

How have CLVT shares performed in 2024?

Clarivate's stock was trading at $9.26 at the start of the year. Since then, CLVT stock has decreased by 19.8% and is now trading at $7.43.
View the best growth stocks for 2024 here
.

Are investors shorting Clarivate?

Clarivate saw a decrease in short interest in the month of February. As of February 29th, there was short interest totaling 34,360,000 shares, a decrease of 10.7% from the February 14th total of 38,480,000 shares. Based on an average trading volume of 4,300,000 shares, the short-interest ratio is presently 8.0 days. Approximately 9.3% of the shares of the company are sold short.
View Clarivate's Short Interest
.

When is Clarivate's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our CLVT earnings forecast
.

How were Clarivate's earnings last quarter?

Clarivate Plc (NYSE:CLVT) issued its quarterly earnings results on Tuesday, February, 27th. The company reported $0.21 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.21. The business had revenue of $683.70 million for the quarter, compared to analyst estimates of $687.80 million. Clarivate had a negative net margin of 34.66% and a positive trailing twelve-month return on equity of 9.95%. The firm's revenue for the quarter was up 1.2% on a year-over-year basis. During the same period last year, the business earned $0.20 EPS.

What ETF holds Clarivate's stock?

iShares MSCI USA Size Factor ETF holds 68,505 shares of CLVT stock, representing 0.20% of its portfolio.

What guidance has Clarivate issued on next quarter's earnings?

Clarivate issued an update on its FY24 earnings guidance on Tuesday, February, 27th. The company provided EPS guidance of $0.70 to $0.80 for the period, compared to the consensus earnings per share estimate of $0.85. The company issued revenue guidance of $2.57 billion to $2.67 billion, compared to the consensus revenue estimate of $2.69 billion.

Who are Clarivate's major shareholders?

Clarivate's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Exor N.V. (9.90%), Generation Investment Management LLP (4.42%), Baupost Group LLC MA (3.84%), Glenview Capital Management LLC (3.71%), Vanguard Group Inc. (1.24%) and Vanguard Group Inc. (1.23%). Insiders that own company stock include Andrew Miles Snyder, Blucher Sheryl G Von, Corp Onex, James Gordon Samson, Jeff Roy, Mukhtar Ahmed, Richard Hanks and Richard Roedel.
View institutional ownership trends
.

How do I buy shares of Clarivate?

Shares of CLVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CLVT) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners